Speaker
VP of Research & Development, Constructive Bio
Daniel de la Torre, VP of Research & Development, Constructive Bio, spoke at 2nd Obesity & Weight Loss Drug Development Summit Europe (Munich, Germany, 28–29 Oct 2026) in the session “Optimising Supply Chain & Manufacturing Strategies to Scale Obesity Therapeutics, Reduce Costs & Expand Patient Access”.
28–29 Oct 2026Munich, Germany
Translational Research Associate, Resalis Therapeutics
Director - Scientific, Gubra
Executive Board Member and Chief Scientific Officer, APHAIA Pharma AG
Chief Executive & Scientific Officer, iBio
Head of Project Management, Cytoo
Professor, University of Aberdeen
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Daniel de la Torre, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].